Human Genome

This strand of the project reconstructs the efforts to determine the fine chemical sequence that constitutes human genetic material. Its starting point is investigating different human genome initiatives that proliferated in countries like Italy, France, Britain and the United States during the second half of the 1980s. These independent, national projects not always sought to sequence the whole human genome. However, they increased their coordination after 1990 and gradually led to a concerted, international effort to complete the human genome sequence. What we understand today as the Human Genome Project is this unified, international endeavour that emerged from initially unconnected and contradicting national initiatives. 

The increasing internationalisation of the Human Genome Project triggered a change in sequencing strategies. When the project was still dominated by national initiatives, there was an expectation that the human genome sequence would be achieved by pooling small contributions from a relatively large number of laboratories. The early coordination efforts at the European level – the Human Genome Analysis Programme of the European Commission – sought to create an infrastructure in which laboratories in the fields of human and medical genetics would share the results of their experiments. This would lead to an expanding volume of genomic information, given the interest of these laboratories in sequencing genes connected to human hereditary diseases.

Throughout the 1990s, this strategy was replaced by the establishment of five factory-style centres that systematically sequenced the human genome from one end to the other: the Whitehead Institute, Washington University in St Louis, the Baylor College of Medicine, the Department of Energy’s Joint Genome Institute (all of them in the US) and the Sanger Institute (in the UK). Unlike the medical and human geneticists, researchers at these centres were not involved in the further use of the genomic information. This change of strategy led to the completion of the human genome ahead of schedule, in 2000, but deferred the translation of the information (by clinicians, genetic researchers or pharmaceutical companies) to after its release in open access databases.

The questions on which this strand will focus are:

1) What were the factors shaping the transition towards a more hierarchical and centralised Human Genome Project? What was the role of funders – such as the Wellcome Trust and the US National Institutes of Health – in this transition?

2) What happened with the researchers and institutions involved in the previous pooling and result-sharing approach? How did they translate – or attempted to translate – the genomic data as it was produced?

3) Has the winning approach to the Human Genome Project been retrospectively identified with a unified, publicly-funded, international and open-access initiative? What are the consequences of this – and the implicit forgetting of the pooling and sharing approach – for current translational research building on human genome data?

Latest Blog Posts

The future of sustainable food production?

On July 18th, I attended a horizon-scanning workshop on food sustainability hosted by the Nuffield Council on Bioethics. The aim of the meeting was to scope out the challenges facing food sustainability over the medium and long-term, and to examine what biological research and innovation is being conducted to try … (Read more)


The Canadian chapter of the history of human genomics

Miguel Garcia-Sancho, PI of the TRANSGENE project and lead investigator of the human genome strand, visited Toronto and Montreal last April to conduct historical research and participate in an interdisciplinary workshop on medical innovation. He visited the archives of the University of Toronto Hospital for Sick Children and conducted oral … (Read more)


Exploring pig genetics in France

At the end of November, I followed in the footsteps of many of the pig geneticists whose work I have been researching, and visited the Jouy-en-Josas campus of the French Institut national de la recherche agronomique (INRA), just south of Paris. At there and other INRA sites in Paris itself, … (Read more)


Advisory Board Meeting and Second Phase of Project

First Advisory Board meeting The TRANSGENE team presented its first findings to an Advisory Board comprised by Stephen Hilgartner (Cornell University), Robert Bud (Science Museum, London), Michel Morange (University Paris 6 and Ecole Normale Superieure), Abigail Woods (King’s College, London) and Hans-Jörg Rheinberger (Max Planck Institute for the History of … (Read more)


The unusual pioneer of the Human Genome Project

When we think about prime-movers, proposing for the first time the idea of scientifically tackling the human genome, the usual suspects come to our mind: reputed biomedical Nobel Prize winners such as James Watson, Walter Gilbert or Renato Dulbecco, who formulated their grand idea in the front pages of Science, … (Read more)


TRANSGENE on tour

…at the British Society for the History of Science conference Amongst the sizeable Edinburgh contingent at the annual British Society for the History of Science conference, this year held in York, were representatives from the TRANSGENE project team. Miguel García-Sancho presented the progress on the yeast strand of the project … (Read more)


June events

The TRANSGENE project operates within the Science, Technology and Innovation Studies (STIS) subject group at the University of Edinburgh. This multidisciplinary affiliation, and association with the Institute for the Study of Science, Technology and Innovation (ISSTI) research network, enables us to discuss our work with researchers that have a wide … (Read more)


Classifying people, practices and institutions

Just as classifications of species, genes, stages of development, or macromolecules can shape research in biology, classification in the humanities and social sciences can condition our analyses. In the pig strand of the project I’m working on, classifying people, practices and institutions is necessary. My aim is to explain, so … (Read more)


The yeast telomeres

Writing the history of the yeast genome project starting from the end, more precisely the chromosome ends, can be an instructive exercise. Chromosome ends (telomeres) are specialised structures essential for chromosome maintenance and genome stability. As yeast telomeres are similar in structure and function to the telomeres of the other … (Read more)


Collaborating with the European Bioinformatics Institute (EMBL-EBI)

In March 2017, I am conducting a three-week visiting post-doctoral fellowship at the European Bioinformatics Institute (EMBL-EBI, Cambridge UK), for the bibliometric and “big data” strand of the project. I am collaborating with the EBI’s Literature Services to advance the project’s aims of mapping institutional networks in genomic sequencing initiatives … (Read more)


The history of pig genome research enters the matrix

In the TRANSGENE project we are committed to using approaches from different disciplines to make sense of the historical material, and to generate new data from which to form a picture of the genomic research. One of the key approaches is the use of quantitative methods, imported from the social … (Read more)


Tracing the history of European biotechnology in the HAEU

My week-long visit to the Historical Archives of the European Union (HAEU) in Florence has proved to be a remarkable opportunity for investigating the ‘behind the scenes’ of European biotechnology policies in the 1980s and 1990s. During my visit in Florence I mainly examined documents available in the Gordon Adam’s … (Read more)


Scientific archives and the history of genomics

In November 2016 Miguel Garcia-Sancho, James Lowe and I attended the Workshop on Scientific Archives organised by Anne Flore-Laloë, archivist at the European Molecular Biology Laboratory (EMBL) in Heidelberg. The meeting brought together tens of archivists from Germany, France, Switzerland, UK, US and Canada. The workshop presentations focused on best … (Read more)